Sleep Study Shows 33% of Adults Use Cannabis for Better Rest
New medical survey reveals one-third of adults report cannabis improves sleep quality, highlighting growing mainstream acceptance of therapeutic applications.
A new survey from the American Academy of Sleep Medicine reveals cannabis has entered mainstream sleep therapy, with 33% of adults reporting the plant helps them achieve better rest. The 2025 Sleep Prioritization Survey, published this month, demonstrates how cannabis has evolved from recreational novelty to legitimate wellness tool in consumer minds.
The data presents a compelling case for cannabis companies targeting the sleep wellness market, which generates billions annually through prescription sleep aids and over-the-counter solutions. With only 8% of respondents reporting worse sleep from cannabis use and 11% seeing no effect, the risk-reward profile appears favorable compared to traditional pharmaceutical alternatives that often carry dependency risks and harsh side effects.
This consumer validation arrives as cannabis companies pivot toward medical and wellness applications to drive sustainable revenue growth. Sleep products represent a particularly attractive segment because they appeal to older demographics with higher disposable income and less stigma around medical cannabis use. Companies developing targeted sleep formulations can now point to clinical survey data supporting consumer demand.
The survey results also underscore cannabis normalization accelerating beyond traditional recreational markets. When major medical organizations publish data showing widespread therapeutic cannabis use, it signals mainstream medical acceptance that could influence prescriber attitudes and insurance coverage decisions. This shift creates opportunities for cannabis companies to partner with healthcare providers and integrate into formal treatment protocols.
For investors, sleep-focused cannabis products offer a pathway to premium pricing and brand loyalty that recreational flower cannot match. As competition intensifies in traditional cannabis categories, companies that establish credibility in medical applications like sleep therapy position themselves for higher margins and more defensible market positions. The survey data provides the consumer validation needed to justify increased R&D investment in sleep-specific cannabis formulations.